{
    "eid": "2-s2.0-85124908972",
    "title": "Health Technology Assessment (HTA) evidence, regulatory classification and reimbursement of medicine: The case of glucosamine",
    "cover-date": "2021-11-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacy",
            "@code": "3611",
            "@abbrev": "HEAL"
        },
        {
            "@_fa": "true",
            "$": "Economics, Econometrics and Finance (miscellaneous)",
            "@code": "2001",
            "@abbrev": "ECON"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology, Toxicology and Pharmaceutics (miscellaneous)",
            "@code": "3001",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "glucosamine",
        "Health Technology Assessment (HTA)",
        "osteoarthritis",
        "regulatory classification",
        "reimbursement"
    ],
    "authors": [
        "Parnnaphat Luksameesate",
        "Suthira Taychakhoonavudh"
    ],
    "citedby-count": 2,
    "ref-count": 58,
    "ref-list": [
        "EBM, HTA, and CER: clearing the confusion",
        "Development of archetypes for nonranking classification and comparison of European National Health Technology Assessment systems",
        "Glucosamine therapy for treating osteoarthritis",
        "Who uses glucosamine and why? A study of 266,848 Australians aged 45 years and older",
        "Variability in the prescription of drugs with uncertain effectiveness. The case of SYSADOA in the Basque Country",
        "Prescribing patterns of glucosamine in an older population: a national cohort study",
        "Double-blind clinical evaluation of the relative efficacy of ibuprofen and glucosamine sulphate in the management of osteoarthrosis of the knee in out-patients",
        "Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee",
        "Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebocontrolled clinical trial",
        "Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebocontrolled, double-blind study",
        "The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial",
        "Glucosamine therapy for treating osteoarthritis",
        "Glucosamine: a review of its use in the management of osteoarthritis",
        "Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis",
        "Additive effects of glucosamine or risedronate for the treatment of osteoarthritis of the knee combined with home exercise: a prospective randomized 18-month trial",
        "Efficacy and safety of glucosamine sulfate in the management of osteoarthritis: evidence from real-life setting trials and surveys",
        "Crystalline glucosamine sulfate in the management of knee osteoarthritis: efficacy, safety, and pharmacokinetic properties",
        "Risk of bias and brand explain the observed inconsistency in trials on glucosamine for symptomatic relief of osteoarthritis: a meta-analysis of placebo-controlled trials",
        "A review of glucosamine for knee osteoarthritis: why patented crystalline glucosamine sulfate should be differentiated from other glucosamines to maximize clinical outcomes",
        "Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials",
        "Effects of glucosamine sulfate on the use of rescue non-steroidal anti-inflammatory drugs in knee osteoarthritis: results from the Pharmaco-Epidemiology of GonArthroSis (PEGASus) study",
        "Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy",
        "Chitins and chitosans as immunoadjuvants and non-allergenic drug carriers",
        "Glucosamine sulphate in the treatment of knee osteoarthritis: cost-effectiveness comparison with paracetamol",
        "The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation",
        "Cost-effectiveness analysis of glucosamine sulphate for the treatment of osteoarthritis in Thailand",
        "Cost-effectiveness evaluation of glucosamine for osteoarthritis based on simulation of individual patient data obtained from aggregated data in published studies"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": []
}